DrugDashboards

Vancomycin

Vancomycin · VANCOMYCIN 1 g/200mL · Injection, Solution · Intravenous · Xellia Pharmaceuticals USA LLC

NDC 70594-0042-02 · 6 BAG in 1 CARTON / 200 mL in 1 BAG · NDA · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

All Part D pricing →

Matched to CMS's representative package for this drug (NDC 00143-9472-12) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.

ⓘ How this was built
Data sources
  • CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method

Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Plans pay at point of saleⓘ
$0.0940per unit
middle half $0.0937–$0.0940 · 670 plans · Apr 1, 2026
Est. net of rebatesⓘ
$0.0564–$0.0705
brand drug — est. 25-40% rebate off the price at left
Coverage & restrictions
12%of plans cover it
tier 4 · prior auth 0% · step therapy 0% · qty limit 0%

*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 2 quarters since 2024.

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $53.21 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA211962
TE code
—
Approval date
Feb 15, 2019
Patents / exclusivity
42 patents, 0 exclusivities
TypeNumber / codeExpires
patent10188697Nov 6, 2035
patent10039804Nov 6, 2035
patent10188697Nov 6, 2035
patent10188697Nov 6, 2035
patent10039804Nov 6, 2035
patent11517609Nov 6, 2035
patent11517609Nov 6, 2035
patent11517609Nov 6, 2035
patent11517609Nov 6, 2035
patent11517609Nov 6, 2035
patent11517609Nov 6, 2035
patent11517609Nov 6, 2035

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Vancomycin (Injection, Solution)

LabelerStrengthFirst seenLast seen
Hikma Pharmaceuticals USA Inc.VANCOMYCIN 1.5 g/300mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.VANCOMYCIN 2 g/400mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.VANCOMYCIN 1.25 g/250mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.VANCOMYCIN 500 mg/100mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.VANCOMYCIN 1.75 g/350mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.VANCOMYCIN 750 mg/150mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.VANCOMYCIN 1 g/200mLJul 15, 2026Sep 2, 2026
Xellia Pharmaceuticals USA LLCVANCOMYCIN 750 mg/150mLJul 15, 2026Sep 2, 2026
Xellia Pharmaceuticals USA LLCVANCOMYCIN 1 g/200mLJul 15, 2026Sep 2, 2026
Xellia Pharmaceuticals USA LLCVANCOMYCIN 1.25 g/250mLJul 15, 2026Sep 2, 2026
Xellia Pharmaceuticals USA LLCVANCOMYCIN 1.5 g/300mLJul 15, 2026Sep 2, 2026
Xellia Pharmaceuticals USA LLCVANCOMYCIN 1.75 g/350mLJul 15, 2026Sep 2, 2026
Xellia Pharmaceuticals USA LLCVANCOMYCIN 2 g/400mLJul 15, 2026Sep 2, 2026
Xellia Pharmaceuticals USA LLCVANCOMYCIN 500 mg/100mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Vancomycin — NDC 70594-0042-02," retrieved September 3, 2026, https://drugdashboards.com/drug/70594004202.

Free to cite with attribution — see how the data is put together.